Skip to content

Epidural Stimulation After Neurologic Damage: Long-Term Outcomes

Epidural Stimulation After Neurologic Damage: Long-Term Outcomes

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05705453
Acronym
LTO
Enrollment
50
Registered
2023-01-30
Start date
2023-03-01
Completion date
2034-04-01
Last updated
2025-03-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

SCI - Spinal Cord Injury

Keywords

spinal cord stimulation, epidural stimulation

Brief summary

This study will evaluate the long-term effect of chronic spinal cord stimulation to restore volitional movement for patients with chronic spinal cord injuries.

Detailed description

Participants will be enrolled in this study for the duration of 10 years. They will need to come to Minneapolis twice a year for the Brain Motor Control Assessment and will be given different settings within their Spinal Cord Stimulator (SCS) programing.

Interventions

Stimulation of the spinal cord from the epidural space.

Sponsors

University of Minnesota
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
22 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* 22 years of age or older * Able to undergo the informed consent process * Stable spinal cord injury * International Standards for Neurological Classification of Spinal Cord Injury (ISNCSCI) neurologic level of injury below C5 * No ventilator dependency within the last year * American Spinal Injury Association (AISA) imparement scaleA or B in the absence of spinal cord stimulation * Medically stable in the judgment of the Principal investigator * Greater than 1 year since initial injury and at least 6 months from any required spinal instrumentation and 2 months from spinal cord stimulator surgery * Has an existing and functional implanted spinal cord stimulator system that is FDA approved and can be corroborated by hospital documentation * Spinal imaging of the stimulator system

Exclusion criteria

* Current and anticipated need for opioid pain medications or pain that would prevent full participation in the rehabilitation program in the judgment of the principal investigator * Use of botulinum toxin (Botox) injections in the previous six months * Clinically significant mental illness in the judgment of the principal investigator * Other conditions or medications that would make the subject unable to participate in testing/rehabilitation in the judgment of the principal investigator * Nonfunctional spinal cord stimulator or near end-of-life, determined by the PI * Current Pregnancy * Current pain relief from the spinal cord stimulator if the indication for implantation was for management of chronic pain.

Design outcomes

Primary

MeasureTime frameDescription
Change in Volitional electromyography (EMG) power10 yearsThe measurement of volitional change using EMG during the Brain Motor Control assessment between nonstimulation baseline and stimulation

Secondary

MeasureTime frameDescription
Prediction of power preferences10 yearsPrediction of power of preference models built based on evaluations of stimulation settings.

Countries

United States

Contacts

Primary ContactStudy Coordinator
estand@umn.edu612-873-9113
Backup ContactStudy Coordinator
rnl@umn.edu612-873-9113

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026